Insight into Metabolic 1H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions

Insight into Metabolic 1H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions

BackgroundProgressive multifocal leukoencephalopathy (PML) is a severe complication of immunosuppressive therapies, especially of natalizumab in relapsing–remitting multiple sclerosis (MS). Metabolic changes within PML lesions have not yet been described in natalizumab-associated PML in MS patients....

Full description

Bibliographic Details
Main Authors: Ruth Schneider, Barbara Bellenberg, Robert Hoepner, Gisa Ellrichmann, Ralf Gold, Carsten Lukas
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-09-01
Series:Frontiers in Neurology
Subjects:
1H magnetic resonance spectroscopy
multiple sclerosis
natalizumab
progressive multifocal leukoencephalopathy
PML lesions
immune reconstitution inflammatory syndrome
Online Access:http://journal.frontiersin.org/article/10.3389/fneur.2017.00454/full

Internet

http://journal.frontiersin.org/article/10.3389/fneur.2017.00454/full

Similar Items